Surface crystallization of indomethacin below T g

Pharmaceutical Research

Volumn 23, Issue 10, 2006, Pages 2350-2355

  Wu, Tian ^a   Yu, Lian ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Amorphous solid; Crystallization kinetics; Glass transition; Indomethacin; Physical stability; Surface crystallization

Indexed keywords

INDOMETACIN;

ARTICLE; CRYSTALLIZATION; KINETICS; PARTICLE SIZE; POWDER DIFFRACTION; PRIORITY JOURNAL; SURFACE PROPERTY; X RAY DIFFRACTION;

ALGORITHMS; CRYSTALLIZATION; INDOMETHACIN; PARTICLE SIZE; SURFACE PROPERTIES; TEMPERATURE; X-RAY DIFFRACTION;

EID: 33749432466     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9023-4     Document Type: Article

References (19)

1. P. W. McMillan. The crystallization of glasses. J. Non-Cryst. Solids 52:(1-3), 67-76 (1982).
2. E. D. Zanotto. Experimental studies of surface nucleation and crystallization of glasses. Ceram. Trans.: Nucleation and Crystallization in Liquids and Glasses 30:65-74 (1993).
3. D. Mahlin, J. Berggren, G. Alderborn, and S. Engstrom. Moisture-induced surface crystallization of spray-dried amorphous lactose particles studied by atomic force microscopy. J. Pharm. Sci. 93:(1), 29-37 (2004).
4. T. Y. Shen, T. B. Windholz, A. Rosegay, B. E. Witzel, A. N. Wilson, J. D. Willett, W. J. Holtz, R. L. Ellis, A. R. Matzuk, S. Lucas, C. H. Stammer, F. W. Holly, L. H. Sarett, E. A. Risley, G. W. Nuss, and C. A. Winter. Nonsteroid antiinflammatory agents. J. Am. Chem. Soc. 85:488-489 (1963).
5. C. A. Winter, E. A. Risley, and G. W. Nuss. Antiinflammatory and antipyretic activities of Indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2- methylindole-3-acetic acid. J. Pharmacol. Exp. Ther. 141:(3), 369-376 (1963).
6. H. Imaizumi, N. Nambu, and T. Nagai. Stability and several physical properties of amorphous and crystalline form of indomethacin. Chem. Pharm. Bull. 28:(9), 2565-2569 (1980).
7. E. Fukuoka, M. Makita, and S. Yamamura. Some physicochemical properties of glassy indomethacin. Chem. Pharm. Bull. 34:(10), 4314-4321 (1986).
8. M. Yoshioka, B. C. Hancock, and G. Zografi. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J. Pharm. Sci. 83:(12), 1700-1705 (1994).
9. X. Chen, K. R. Morris, U. J. Griesser, S. R. Byrn, and J. G. Stowell. Reactivity differences of indomethacin solid forms with ammonia gas. J. Am. Chem. Soc. 124:(50), 15012-15019 (2002).
10. S. Vyazovkin and I. Dranca. Physical stability and relaxation of amorphous indomethacin. J. Phys. Chem. B 109:(39), 18637-18644 (2005).
11. M. Otsuka, T. Matsumoto, and N. Kaneniwa. Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. Chem. Pharm. Bull. 34:(4), 1784-1793 (1986).
12. M. Otsuka and N. Kaneniwa. A kinetic study of the crystallization process of noncrystalline indomethacin under isothermal conditions. Chem. Pharm. Bull. 36:(10), 4026-4032 (1988).
13. K. J. Crowley and G. Zografi. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability. J. Pharm. Sci. 91:(2), 492-507 (2002).
14. V. Andronis and G. Zografi. Crystal nucleation and growth of indomethacin polymorphs from the amorphous state. J. Non-Cryst. Solids 271:(3), 236-248 (2000).
15. J. Schmelzer, R. Pascova, J. Moeller, and I. Gutzow. Surface-induced devitrification of glasses: the influence of elastic strains. J. Non-Cryst. Solids 162:(1-2), 26-39 (1993).
16. R. Tromp. Surface diffusion: atoms go underground. Nature Materials 2:(4), 212-213 (2003).
17. E. Fukuoka, M. Makita, and S. Yamamura. Glassy state of pharmaceuticals. III. Thermal properties and stability of glassy pharmaceuticals and their binary glass systems. Chem. Pharm. Bull. 37:(4), 1047-1050 (1989).
18. S. Chen, H. Xi, and L. Yu. Cross nucleation between ROY polymorphs. J. Am. Chem. Soc. 127:17439-17444 (2005).
19. J. Tao and L. Yu. Kinetics of cross-nucleation between polymorphs. J. Phys. Chem. B 110:7098-7101 (2006).